A portion of the disclosure of this patent document contains material which is subject to copyright protection. This patent document may show and/or describe matter which is or may become trade dress of the owner. The copyright and trade dress owner has no objection to the facsimile reproduction by anyone of the patent disclosure as it appears in the Patent and Trademark Office patent files or records, but otherwise reserves all copyright and trade dress rights whatsoever.
An adjustable harvest valve assembly for a bioreactor system and methods of use therefore.
Efforts of biopharmaceutical companies to discover new biological drugs have increased exponentially during the past two decades. Bioreactors have been used for cultivation of microbial organisms for production of various biological or chemical products in the pharmaceutical, biotechnological, and beverage industry. Most biological drugs are produced by cell culture or microbial fermentation processes which require sterile bioreactors and an aseptic culture environment.
A production bioreactor contains culture medium in a sterile environment that provides various nutrients required to support growth of the biological agents of interest. Stainless steel tanks with horizontal stirring mechanisms have long been the only option for large scale production of biological products in suspension culture. Manufacturing facilities with conventional stainless bioreactors, however, face numerous problems such as large capital investments for construction, high maintenance costs, long lead times, and inflexibilities for changes in manufacturing schedules and production capacities. Such bioreactors can only be reused for the next batch of biological agents after cleaning and sterilization of the vessel. These procedures require a significant amount of time and resources, especially to monitor and to validate each cleaning step prior to reuse for production of biopharmaceutical products.
Scaling up cell culture processes in bioreactors can pose numerous engineering challenges, much of which has been addressed and resolved for the therapeutic protein market, for which well-established cell lines such as CHO (Chinese hamster ovarian) are used. These cell lines, which have been adapted from adherent culture over time to grow in single-cell suspension, are fairly robust to shear stress and are even able to handle perfusion culture modes, where fresh cell culture medium is added to the bioreactor in a continuous manner as spent medium is withdrawn and cells are retained in the bioreactor.
Cells used in cell therapy market, however, are often primary cells such as mesenchymal stem cells and embryonic stem cells, newly derived from human donors and therefore are more shear-sensitive and are adherent-based in nature (i.e. they will grow in aggregates or on scaffolds such as microcarriers).
Cell culture medium exchanges for these primary cells are typically performed in discrete mode of removing spent medium first and then replacing with fresh medium, not in perfusion mode of removing and replacing medium continuously to avoid unnecessary shearing effect on cells. To remove spent medium from a bioreactor, agitation is first turned off and cells (in aggregates or on microcarriers) are allowed to settle to the bottom, before spent medium is removed.
In addition to medium exchanges, the method of removing and replacing cell-free liquid is also necessary during in situ harvest in a bioreactor, where spent medium is first withdrawn and then cells are rinsed using buffered saline solution in a number of wash steps before they are dissociated via enzyme and then quenched with medium. The in situ harvest process therefore adds to the number of cell-free liquid removal and addition steps required during a cell culture run, the total number for which could be up to 20 times per run.
Despite a proliferation of bioreactor designs for culturing primary cells, the options for cell culture medium exchange are relatively limited and time-consuming, and thus there is a need for a faster and easier technique.
The present application discloses adjustable harvest valve assemblies for a bioreactor system which enables exchange/replenishment of cell culture medium in bioreactors used to culture primary cells.
The present application provides an adjustable harvest valve assembly for a bioreactor system which offers all of the benefits of a harvest port, while allowing cell-free liquid to be collected at various liquid heights and multiple times throughout the run, all of which are critical requirements when dealing with culturing of primary cells.
Current techniques are limited. In a small bench-top scale system such as a spinner flask, spent medium or other cell-free liquid is manually removed through a port with a removable cap using a pipette in a biosafety cabinet; for larger bioreactor systems, a harvest port or a dip tube would be required. Although the pipetting step at small scale is relatively straightforward, removing cell-free liquid out of a large bioreactor can be problematic for a number of reasons, and the present application contemplates a number of solutions, as follows:
In view of these challenges, an adjustable height harvest valve assembly is described which is mounted to and extends through the wall of a lower section of the bioreactor for ease of liquid removal. The assembly features a gate valve at the upper end of a hollow harvest tube that is mounted to the bottom wall and can be elevated into the bioreactor from below. The harvest tube slides through a harvest port in the bottom wall which provides a fluid seal therearound. In this way, the gate valve may be axially positioned at a desired height within the bioreactor for liquid removal.
In a preferred embodiment, the bioreactor includes a rigid outer container or housing (not shown) that receives a single-use bioreactor vessel 20 of sufficient size to contain a fluid to be mixed. A variety of different sizes of bioreactors are used from the maximum working volume of 3 L up to 500 L, and which can process various liquid volumes in each vessel. The bioreactor vessel 20 is preferably a disposable bioreactor bag 20 usually made of a three-layer plastic foil, such as polyethylene terephthalate, although the harvesting assembly described herein may also be used with a rigid bioreactor vessel.
One embodiment of an adjustable height harvest valve assembly of the present application seen in
The rigid tube 26 is secured and mates with a lower rigid block 32 having a cross bore (not numbered), and a lower or outer aperture (not shown) of the tube 26 is positioned to align with the bore of the block 32.
A rotating flow gate valve 40 as seen in
The block 32 further mates and seals with a tubing connector 46, which has a hose barb or other coupler for attaching silicone tubing or other tubing for biopharmaceutical use as desired by the end user. If desired, rigid block 32 and tubing connector 46 could be manufactured as one part, but in Error! Reference source not found. two parts are shown, as tubing connector 46 is an off-the-shelf component that is readily available in the market and rigid block 32 is more easily machined by itself.
A longitudinally flexible sheath 48, secured around the valve assembly maintains sterility of inner components during valve movements. As seen in
An optional locking mechanism may also be used with the adjustable harvest valve assembly to maintain the position of the valve. One embodiment of this locking mechanism shown in
The adjustable height harvest valve assembly is desirably manufactured, packaged, and shipped to the user in the position as depicted in Error! Reference source not found., so that at the start of a cell culture run, the port 22 remains plugged. There could be a mechanism on the bag assembly to ensure the valve is not inadvertently extended, either during shipping or by the user during bag installation into the bioreactor housing, such as for instance the locking mechanism described above.
During medium exchange/harvest step, and once impeller agitation is stopped and cells are allowed to settle to the bottom of the bioreactor bag 20, the user manually extends the rigid tube 26 to an extended position within the bag. Even though Figure shows the fully extended position, tube 26 may be extended to any height between the maximum and minimum extension (while still exposing the gate valve 40 to fluid). The valve 40 is then turned 90 degrees (¼ turn) or other predetermined amount about its axis to align the hole(s) 30 on rigid tube 26 and apertures 45 on the rotating flow gate valve 40 and allow liquid to flow through the rigid tube 26, rigid block 32, and tubing connector 46 with flexible biopharmaceutical tubing. To stop the flow of liquid, the user rotates the valve 40 about its axis back to the position as depicted in Figure. The valve assembly is then retracted fully to plug the port 22, as depicted in Error! Reference source not found.. A similar sequence is shown in
The adjustable height harvest valve assembly is shown mounted to a bottom wall of the bioreactor bag 20, which is desirable as it facilitates fluid flow by gravity. However, the valve assembly may be positioned at various locations around the bioreactor bag 20, and fluid extraction may be activated with suction.
In another embodiment of the adjustable height harvest valve assembly, there is no rotating valve 40 for aligning holes(s) with the outer tube 26, and cell-free liquid is allowed to flow out once the rigid tube 26 is extended into the bioreactor bag. A clamp, stopcock, or other such valve is then loosened or removed on the flexible tubing attached to the tubing connector 46 to initiate flow. In this version of the design, there would be no rotating movement of the valve 40 but only an axial movement of the tube 26. This embodiment offers the advantage of having a simpler design for manufacturing and operation. However, the no valve option could allow some cell collection in the rigid tube 26 in the first instance of using this valve assembly for each run as there would be no liquid in the tube 26. The valve prevents any ingress of fluid prior to elevating the tube 26 to the desired height.
The adjustable harvest valve assembly as depicted in Error! Reference source not found. and Figure would most likely be a part of the single-use bag assembly and would be packaged and sterilized by gamma radiation, to be used in a single-use bioreactor system, but this design could also be applied to conventional stainless steel bioreactor systems as well. The optional locking mechanism as depicted in
A mixing or agitating wheel 106 is mounted wholly within the container 104 for rotation within the semi-cylindrical lower section. Preferably, the wheel 106 features a series of vanes 108 on its exterior for stirring the solution within the container 104, and also preferably includes inner vanes (not shown). The wheel 106 rotates about a horizontal axis on hubs 110 secured to the front and/or back walls of the container 104 (i.e., only one wheel hub 110 may be secured to the container 104). In a preferred embodiment, the base unit 102 includes an upstanding cabinet 112 within which is housed a drive system including rotating magnets (not shown). Corresponding magnets or ferromagnetic material mounted around the wheel 106 allow coupling of the drive system to enable rotation of the wheel from outside the container 104, thus eliminating seals and the like which might contaminate the solution within the container. In a preferred embodiment, the volume capacity of the container 104 is between 0.05-1.0 L, although the system can be scaled up for larger capacities.
The illustrated bioreactor 100 is for use inside CO2 incubators, which are typically run with temperature control and with a fixed percentage of CO2 in air. Consequently, independent pH and DO controls for the bioreactor 100 are not necessary.
Throughout this description, the embodiments and examples shown should be considered as exemplars, rather than limitations on the apparatus and procedures disclosed or claimed. Although many of the examples presented herein involve specific combinations of method acts or system elements, it should be understood that those acts and those elements may be combined in other ways to accomplish the same objectives. Acts, elements and features discussed only in connection with one embodiment are not intended to be excluded from a similar role in other embodiments.
As used herein, “plurality” means two or more. As used herein, a “set” of items may include one or more of such items. As used herein, whether in the written description or the claims, the terms “comprising”, “including”, “carrying”, “having”, “containing”, “involving”, and the like are to be understood to be open-ended, i.e., to mean including but not limited to. Only the transitional phrases “consisting of” and “consisting essentially of”, respectively, are closed or semi-closed transitional phrases with respect to claims. Use of ordinal terms such as “first”, “second”, “third”, etc., in the claims to modify a claim element does not by itself connote any priority, precedence, or order of one claim element over another or the temporal order in which acts of a method are performed, but are used merely as labels to distinguish one claim element having a certain name from another element having a same name (but for use of the ordinal term) to distinguish the claim elements. As used herein, “and/or” means that the listed items are alternatives, but the alternatives also include any combination of the listed items.
This patent claims priority from the following provisional patent applications: Provisional Patent Application No. 62/273,834, entitled ADJUSTABLE HEIGHT HARVEST VALVE ASSEMBLY FOR BIOREACTORS, filed Dec. 31, 2015.
Number | Date | Country | |
---|---|---|---|
62273834 | Dec 2015 | US |